GlassScriptPhysician profile
Grace M Mooken
NPI 1144580325
$3,608.52
in general payments reported to CMS, 2019-2025
40 companies · $498 in 2025
The $498 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $319 · 2021: $427 · 2022: $468 · 2023: $791 · 2024: $667 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,857 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.90 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $567.32 | 2019-2023 | |
| Astellas Pharma US INC | $340.79 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $332.93 | 2019-2025 | Slynd |
| Pfizer INC. | $293.00 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $258.33 | 2022-2025 | |
| Organon LLC | $200.10 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $192.34 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $189.19 | 2019-2025 | Aptima, Thinprep 2000 Processor, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $136.47 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Sage Therapeutics, LLC | $102.42 | 2023-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $87.49 | 2019-2021 | |
| Minerva Surgical, INC | $69.08 | 2021 | |
| Mylan Pharmaceuticals INC. | $63.76 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.29 | 2020-2024 | |
| Pacira Pharmaceuticals Incorporated | $55.86 | 2021-2024 | Exparel |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $51.54 | 2021-2022 | |
| Innovation Technologies INC | $48.63 | 2023-2024 | Irrisept |
| Medtronic, INC. | $43.03 | 2023-2024 | V-Loc 180, Ligasure |
| Amag Pharmaceuticals, INC. | $41.32 | 2019-2021 | |
| Becton, Dickinson and Company | $39.72 | 2019-2024 | Bd Onclarity |
| Aspira Women'S Health INC | $34.78 | 2019-2022 | |
| Baxter Healthcare | $31.93 | 2025 | Tisseel |
| Gynesonics, INC. | $29.40 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $29.00 | 2021-2022 | |
| Allergan, INC. | $27.46 | 2019 | |
| Lupin INC. | $27.23 | 2020 | |
| American Regent | $26.38 | 2025 | Injectafer |
| Therapeuticsmd, INC. | $25.51 | 2019-2020 | |
| Cook Medical LLC | $21.28 | 2023 | Cook |
| Coopersurgical, INC. | $19.76 | 2025 | Paragard T 380a |
| Smith+Nephew, INC. | $19.65 | 2019 | |
| Duchesnay USA Incorporated | $19.18 | 2019 | |
| Supernus Pharmaceuticals, INC. | $18.70 | 2025 | Qelbree |
| Boston Scientific Corporation | $18.17 | 2025 | General - Female Sui |
| Agile Therapeutics, INC. | $17.50 | 2021 | |
| Novum Pharma, LLC | $16.37 | 2019 | |
| Molnlycke Health Care US, LLC | $15.01 | 2023 | Mepilex Border Post-Op Ag, Mepilex Border Flex, Avance |
| Monaghan Medical Corporation | $14.54 | 2024 | Aerobika |
| Alnylam Pharmaceuticals INC. | $14.40 | 2021 | |
| Evofem Biosciences, INC. | $11.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Mooken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.